IGC PHARMA, INC. Comprehensive Income
IGC PHARMA, INC. (IGC) reported Comprehensive Income of -$2.93 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-14
- IGC PHARMA, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$2.93M.
- IGC PHARMA, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$2.41M.
- IGC PHARMA, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$744.00K.
- IGC PHARMA, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$1.84M.
- IGC PHARMA, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$7.15M.
- IGC PHARMA, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$13.03M.
- IGC PHARMA, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$11.93M.
- IGC PHARMA, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$15.21M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$2.93M 10-Q · filed 2026-08-14 | -$5.34M 10-Q · filed 2026-08-14 | -$6.09M derived: sum of 3 quarters · filed 2026-08-14 | -$7.93M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$2.41M 10-Q · filed 2026-05-15 | -$3.15M derived: sum of 2 quarters · filed 2026-05-15 | -$4.99M derived: sum of 3 quarters · filed 2026-05-15 | -$6.60M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$744.00K derived: 10-KT 9 month − 10-Q 6 month · filed 2026-03-18 | -$2.58M derived: sum of 2 quarters · filed 2026-03-18 | -$4.19M 10-KT · filed 2026-03-18 | -$5.38M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-09-30 | -$1.84M 10-Q · filed 2025-11-14 | -$3.44M 10-Q · filed 2025-11-14 | -$4.63M derived: sum of 3 quarters · filed 2026-08-14 | -$6.48M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$1.60M 10-Q · filed 2026-08-14 | -$2.79M 10-Q · filed 2026-08-14 | -$4.64M derived: sum of 3 quarters · filed 2026-08-14 | -$6.37M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$1.19M 10-Q · filed 2026-05-15 | -$3.04M derived: sum of 2 quarters · filed 2026-05-15 | -$4.77M derived: sum of 3 quarters · filed 2026-05-15 | -$7.15M 10-KT · filed 2026-03-18 |
| 2024-12-31 | -$1.85M 10-Q · filed 2025-02-14 | -$3.58M derived: sum of 2 quarters · filed 2025-11-14 | -$5.96M 10-KT · filed 2026-03-18 | -$8.84M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-09-30 | -$1.73M 10-Q · filed 2025-11-14 | -$4.11M 10-Q · filed 2025-11-14 | -$7.00M derived: sum of 3 quarters · filed 2025-11-14 | -$12.57M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$2.38M 10-Q · filed 2025-08-14 | -$5.26M derived: sum of 2 quarters · filed 2025-08-14 | -$10.84M derived: sum of 3 quarters · filed 2025-08-14 | -$13.35M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$2.88M derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-27 | -$8.45M derived: sum of 2 quarters · filed 2025-06-27 | -$10.97M derived: sum of 3 quarters · filed 2025-06-27 | -$13.03M 10-K · filed 2025-06-27 |
| 2023-12-31 | -$5.57M 10-Q · filed 2025-02-14 | -$8.09M derived: sum of 2 quarters · filed 2025-02-14 | -$10.15M 10-Q · filed 2025-02-14 | -$14.14M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-09-30 | -$2.51M 10-Q · filed 2024-11-12 | -$4.58M 10-Q · filed 2024-11-12 | -$8.57M derived: sum of 3 quarters · filed 2024-11-12 | -$10.88M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$2.07M 10-Q · filed 2024-08-07 | -$6.05M derived: sum of 2 quarters · filed 2024-08-07 | -$8.37M derived: sum of 3 quarters · filed 2024-08-07 | -$10.99M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | -$3.99M derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-24 | -$6.30M derived: sum of 2 quarters · filed 2024-06-24 | -$8.92M derived: sum of 3 quarters · filed 2024-06-24 | -$11.93M 10-K · filed 2024-06-24 |
| 2022-12-31 | -$2.31M 10-Q · filed 2024-02-14 | -$4.93M derived: sum of 2 quarters · filed 2024-02-14 | -$7.94M 10-Q · filed 2024-02-14 | -$14.65M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-09-30 | -$2.62M 10-Q · filed 2023-11-09 | -$5.63M 10-Q · filed 2023-11-09 | -$12.34M derived: sum of 3 quarters · filed 2023-11-09 | -$14.64M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$3.00M 10-Q · filed 2023-08-10 | -$9.71M derived: sum of 2 quarters · filed 2023-08-10 | -$12.02M derived: sum of 3 quarters · filed 2023-08-10 | -$16.34M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$6.71M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-07 | -$9.01M derived: sum of 2 quarters · filed 2023-07-07 | -$13.34M derived: sum of 3 quarters · filed 2023-07-07 | -$15.21M 10-K · filed 2023-07-07 |
| 2021-12-31 | -$2.30M 10-Q · filed 2023-02-14 | -$6.63M derived: sum of 2 quarters · filed 2023-02-14 | -$8.50M 10-Q · filed 2023-02-14 | -$11.50M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-09-30 | -$4.32M 10-Q · filed 2022-11-01 | -$6.20M 10-Q · filed 2022-11-01 | -$9.20M derived: sum of 3 quarters · filed 2022-11-01 | -$11.48M derived: sum of 4 quarters · filed 2022-11-01 |
| 2021-06-30 | -$1.87M 10-Q · filed 2022-08-05 | -$4.87M derived: sum of 2 quarters · filed 2022-08-05 | -$7.15M derived: sum of 3 quarters · filed 2022-08-05 | -$8.67M derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-03-31 | -$3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-23 | -$5.28M derived: sum of 2 quarters · filed 2022-06-23 | -$6.79M derived: sum of 3 quarters · filed 2022-06-23 | -$8.73M 10-K · filed 2022-06-23 |
| 2020-12-31 | -$2.28M 10-Q · filed 2022-02-10 | -$3.80M derived: sum of 2 quarters · filed 2022-02-10 | -$5.74M 10-Q · filed 2022-02-10 | -$9.16M derived: sum of 4 quarters · filed 2022-02-10 |
| 2020-09-30 | -$1.51M 10-Q · filed 2021-10-29 | -$3.46M 10-Q · filed 2021-10-29 | -$6.87M derived: sum of 3 quarters · filed 2021-10-29 | -$8.52M derived: sum of 4 quarters · filed 2021-10-29 |
| 2020-06-30 | -$1.94M 10-Q · filed 2021-08-11 | -$5.36M derived: sum of 2 quarters · filed 2021-08-11 | -$7.00M derived: sum of 3 quarters · filed 2021-08-11 | -$8.33M derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | -$3.42M derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-14 | -$5.06M derived: sum of 2 quarters · filed 2021-06-14 | -$6.39M derived: sum of 3 quarters · filed 2021-06-14 | -$7.75M 10-K · filed 2021-06-14 |
| 2019-12-31 | -$1.65M 10-Q · filed 2021-02-16 | -$2.97M derived: sum of 2 quarters · filed 2021-02-16 | -$4.33M 10-Q · filed 2021-02-16 | -$5.87M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-09-30 | -$1.32M 10-Q · filed 2020-11-20 | -$2.68M 10-Q · filed 2020-11-20 | -$4.22M derived: sum of 3 quarters · filed 2020-11-20 | -$5.13M derived: sum of 4 quarters · filed 2020-11-20 |
| 2019-06-30 | -$1.36M 10-Q · filed 2020-08-19 | -$2.90M derived: sum of 2 quarters · filed 2020-08-19 | -$3.81M derived: sum of 3 quarters · filed 2020-08-19 | -$5.00M derived: sum of 4 quarters · filed 2020-08-19 |
| 2019-03-31 | -$1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-13 | -$2.45M derived: sum of 2 quarters · filed 2020-07-13 | -$3.64M derived: sum of 3 quarters · filed 2020-07-13 | -$4.46M 10-K · filed 2020-07-13 |
| 2018-12-31 | -$909.00K 10-Q · filed 2020-02-10 | -$2.10M derived: sum of 2 quarters · filed 2020-02-10 | -$2.92M 10-Q · filed 2020-02-10 | |
| 2018-09-30 | -$1.19M 10-Q · filed 2019-11-06 | -$2.01M 10-Q · filed 2019-11-06 | ||
| 2018-06-30 | -$819.00K 10-Q · filed 2019-08-09 | |||
| 2018-03-31 | -$1.79M 10-K · filed 2019-06-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |